Van Leeuwenhoeck Research initiates coverage on Pharming (PHARM.AS) rerating justified
A new analyst report from Van Leeuwenhoeck is published.
Visit our Analyst Coverage & Reports page to read more reports from Van Leeuwenhoeck Research.
Sijmen de Vries, CEO: T: +31 (0)71 524 7400
“This update is for informational purposes only and is not viewed by Pharming to be of a price sensitive nature”